Divisadero Street Capital Management LP Has $16.80 Million Stake in Maximus, Inc. $MMS

Divisadero Street Capital Management LP raised its stake in Maximus, Inc. (NYSE:MMS) by 93.5% during the third quarter, HoldingsChannel.com reports. The fund owned 183,872 shares of the health services provider’s stock after acquiring an additional 88,872 shares during the quarter. Divisadero Street Capital Management LP’s holdings in Maximus were worth $16,800,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Richardson Financial Services Inc. boosted its stake in shares of Maximus by 123.1% in the 3rd quarter. Richardson Financial Services Inc. now owns 348 shares of the health services provider’s stock valued at $32,000 after purchasing an additional 192 shares in the last quarter. Cullen Frost Bankers Inc. bought a new stake in shares of Maximus in the 3rd quarter worth about $38,000. Canada Pension Plan Investment Board acquired a new stake in shares of Maximus during the 2nd quarter worth about $35,000. Parkside Financial Bank & Trust lifted its holdings in Maximus by 27.2% during the 3rd quarter. Parkside Financial Bank & Trust now owns 1,118 shares of the health services provider’s stock valued at $102,000 after purchasing an additional 239 shares during the last quarter. Finally, GAMMA Investing LLC lifted its holdings in Maximus by 13.9% during the 3rd quarter. GAMMA Investing LLC now owns 1,337 shares of the health services provider’s stock valued at $122,000 after purchasing an additional 163 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Maximus

In other news, CFO David Mutryn acquired 1,000 shares of Maximus stock in a transaction on Monday, February 9th. The shares were purchased at an average price of $75.62 per share, with a total value of $75,620.00. Following the acquisition, the chief financial officer owned 40,037 shares in the company, valued at $3,027,597.94. This represents a 2.56% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Bruce Caswell acquired 3,175 shares of the firm’s stock in a transaction on Tuesday, February 10th. The stock was purchased at an average price of $78.45 per share, for a total transaction of $249,078.75. Following the completion of the transaction, the chief executive officer directly owned 328,013 shares in the company, valued at approximately $25,732,619.85. The trade was a 0.98% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders own 1.80% of the company’s stock.

Analyst Ratings Changes

Several brokerages have weighed in on MMS. Wall Street Zen cut shares of Maximus from a “buy” rating to a “hold” rating in a research note on Monday, February 23rd. Zacks Research upgraded shares of Maximus from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, December 30th. Finally, Weiss Ratings downgraded Maximus from a “buy (b)” rating to a “hold (c+)” rating in a report on Tuesday, February 24th. One research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, Maximus has an average rating of “Buy”.

Maximus Stock Down 0.0%

Shares of NYSE MMS opened at $72.40 on Monday. The firm’s 50-day simple moving average is $84.50 and its 200 day simple moving average is $85.67. The company has a market cap of $3.95 billion, a price-to-earnings ratio of 11.02 and a beta of 0.59. The company has a quick ratio of 2.34, a current ratio of 2.34 and a debt-to-equity ratio of 0.88. Maximus, Inc. has a 12-month low of $64.68 and a 12-month high of $100.00.

Maximus (NYSE:MMS) last posted its quarterly earnings data on Thursday, February 5th. The health services provider reported $1.85 earnings per share for the quarter, beating the consensus estimate of $1.84 by $0.01. Maximus had a net margin of 6.92% and a return on equity of 25.30%. The firm had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.37 billion. During the same quarter last year, the company posted $1.61 EPS. The company’s quarterly revenue was down 4.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. On average, research analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 2nd. Investors of record on Friday, February 13th were given a $0.33 dividend. This is a boost from Maximus’s previous quarterly dividend of $0.30. The ex-dividend date was Friday, February 13th. This represents a $1.32 annualized dividend and a yield of 1.8%. Maximus’s dividend payout ratio is presently 20.09%.

Maximus Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.